Laticort cream 1mg/g 15g №1

Name:
Laticort cream 1mg/g in tubes 15g in pack No. 1
Description:
Homogeneous mass of white color, practically odorless Main active ingredient Hydrocortisone Product form Cream Dosage Hydrocortisone butyrate 1.00 mg per 1 g of cream Indications for useLaticort in the form of a cream is prescribed for external use in the treatment of subacute and chronic uninfected, weeping inflammatory conditions of the skin of various origins, primarily those of an allergic nature, of moderate or severe form, that respond to corticosteroids, with symptoms of severe itching or hyperkeratosis: • atopic, seborrheic dermatitis • allergic contact eczema • psoriasis (see section Application Features) • lupus erythematosus • lichen planus, childhood urticaria • erythema multiforme. Dosage and administration Apply externally. Apply a small amount of ointment to the affected areas of the skin, no more than 1-2 times a day. Treatment should not be continued without interruption for longer than 2 weeks. On the skin of the face, the drug is not used for more than 1 week. Do not use more than one tube of cream per week. Do not use under occlusive dressings. For children older than 2 years, the drug should be used with caution, only if necessary, once a day and on a small area of the skin. Do not use on children’s face. Use during pregnancy and lactation Before using the drug, you should consult a doctor. Laticort can only be used externally in pregnant women for a short time, on a small area of the skin, if the benefits of treatment outweigh the possible risks. Do not use the drug during the first trimester of pregnancy. Laticort can be used in breastfeeding women only on the recommendation of a doctor, with short-term use on a small area of skin. Precautions: Treatment with the drug should not be carried out without interruption for more than 2 weeks. Under the influence of the external use of hydrocortisone butyrate, due to the inhibition of the pituitary-adrenal system, there may be a decrease in the production of adrenocorticotropic hormone (ACTH) by the pituitary gland, as well as a decrease in the level of cortisol in the blood and the development of Itsenko-Cushing’s iatrogenic syndrome, which regresses after stopping treatment. Periodic monitoring of the work of the adrenal cortex is shown by determining the level of cortisol in the blood and urine after stimulation of the adrenal glands with the hormone ACTH. If symptoms of infection are found in the area of application, appropriate antibacterial or antifungal treatment should be carried out. If symptoms of infection do not improve, Laticort should be discontinued until the infection is cleared. The use of the drug on the eyelids or on the skin around the eyelids in patients with narrow or wide anterior chamber angle glaucoma and in people with cataracts should be avoided due to the possibility of exacerbating the symptoms of the disease. Avoid getting the drug in the eyes, open wounds and mucous membranes. If the drug gets into the eyes or mucous membranes, it is recommended to rinse them with plenty of water. As in the case of the use of systemic glucocorticosteroids, after external use of the drug, cataracts and glaucoma or such a rare disease as central serous chorioretinopathy (CSC) may develop. Consult your doctor if you experience blurred vision or other visual disturbances. Apply the cream on the skin of the face, groin and axillary pits only in very necessary cases, due to increased absorption and a high risk of side effects of the drug (telangiectasia, perioral dermatitis), even after short-term use. Do not use under an occlusive dressing (except in cases of severe hyperkeratosis and on the recommendation of a doctor), since such a dressing enhances the absorption of the corticosteroid into the body, moreover, atrophy or stretching of the skin, superinfection may occur. Use this drug with caution in pre-existing skin tissue atrophy, especially in the elderly. Use the drug with particular caution in patients with psoriasis, since topical use of glucocorticosteroids in psoriasis can be dangerous and cause a relapse of the disease due to the development of addiction, the risk of generalized pustular psoriasis and systemic toxicity caused by skin dysfunction. Treat with extreme caution and avoid long-term treatment in children under 2 years of age. For children, who have a higher body surface area to body weight ratio than adults, there is an increased risk of unwanted systemic effects of glucocorticosteroids, including dysfunction of the hypothalamus, pituitary gland, adrenal glands and Itsenko-Cushing’s syndrome. Treatment with corticosteroids can adversely affect the growth and development of children. Contains cetostearyl alcohol which may cause local skin reactions (eg contact dermatitis). Contains methyl hydroxybenzoate, which may cause allergic reactions (possibly delayed). Interaction with other drugs There are no known cases of interaction after external use of glucocorticosteroids. During treatment with glucocorticosteroids, vaccination with live attenuated vaccines is not recommended. Contraindications Laticort cream should not be used: • in case of hypersensitivity to the ingredients of the drug, • in case of bacterial, viral (eg chickenpox, herpes) and fungal infections of the skin, • in case of simple acne, • in case of rosacea (rosacea), • in case of perioral dermatitis , • on large areas of the skin, • with parasitic infections, • ulcerative lesions of the skin, • on the surface of wounds, • with increased fragility of skin vessels, • with eyelid dermatitis, • with skin post-vaccination reactions, • with some malignant skin diseases (for example, syndrome basal cell nevus), • in the presence of adverse reactions caused by corticosteroids (eg, perioral dermatitis, atrophic striae), • in children under two years of age. Active substance Hydrocortisone butyrate 1.00 mg per 1 g of cream Excipients Cetostearyl alcohol, cetomacrogol, liquid paraffin, white petrolatum, methyl parahydroxybenzoate, citric acid monohydrate, sodium citrate, purified water. Overdose Long-term or improper use of the drug or use on large areas of the skin can lead to dysfunction of the pituitary-adrenal system, suppression of the growth and development of children. In severe cases, overdose symptoms such as edema, high blood pressure, hyperglycemia, glucosuria, decreased immunity up to Itsenko-Cushing’s disease may appear. In this case, it is necessary to stop taking the drug or use a less powerful glucocorticosteroid. Side effects May appear: acne, post-steroid purpura, epidermal growth inhibition, subcutaneous tissue atrophy, dry skin, increased hair growth or baldness, depigmentation or skin pigmentation, skin atrophy and stretching, telangiectasia, perioral dermatitis, furunculosis, secondary infection, skin irritation. Occasionally, urticaria or a maculopapular rash or an exacerbation of existing changes may occur. After external use on the skin of the eyelids, glaucoma or cataracts may sometimes appear. Blurred vision is sometimes observed – the frequency of development is unknown. Due to the absorption of hydrocortisone butyrate through the skin, unwanted systemic reactions may occur, especially with prolonged use, use on large areas of the skin, under occlusive dressings and in children. The following undesirable systemic reactions are characteristic of hydrocortisone butyrate: dysfunction of the hypothalamus, pituitary gland, adrenal glands, Itsenko-Cushing’s syndrome, suppression of the growth and development of children, edema, high blood pressure, hyperglycemia, glucosuria, decreased immunity. If any of the side effects listed in the instructions get worse, or if you notice any other side effects not listed in the instructions, tell your doctor. Storage conditionsStore at a temperature not exceeding 25°C. Do not freeze. Keep out of the reach of children. Shelf life – 2 years. Before using the cream, check the expiration date of the drug, which is indicated on the package. Do not use the drug after the expiration date. Buy Laticort cream 1mg/g 15g №1